1
|
Smeraldo A, Ponsiglione AM, Netti PA, Torino E. Artificial neural network modelling hydrodenticity for optimal design by microfluidics of polymer nanoparticles to apply in magnetic resonance imaging. Acta Biomater 2023; 171:440-450. [PMID: 37775077 DOI: 10.1016/j.actbio.2023.09.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Revised: 09/11/2023] [Accepted: 09/17/2023] [Indexed: 10/01/2023]
Abstract
The engineering of nanoparticles impacts the control of their nano-bio interactions at each level of the delivery pathway. Therefore, optimal nanoparticle physicochemical properties should be identified to favour on-target interactions and deliver efficiently active compounds to a specific target. To date, traditional batch processes do not guarantee the reproducibility of results and low polydispersity index of the nanostructures, while microfluidics has emerged as cost effectiveness, short-production time approach to control the nanoparticle size and size distribution. Several thermodynamic processes have been implemented in microfluidics, such as nanoprecipitation, ionotropic gelation, self-assembly, etc., to produce nanoparticles in a continuous mode and high throughput way. In this work, we show how the Artificial Neural Network (ANN) can be adopted to model the impact of microfluidic parameters (namely, flow rates and polymer concentrations) on the size of the nanoparticles. Promising results have been obtained, with the highest model accuracy reaching 98.9 %, thus confirming the proposed approach's potential applicability for an ANN-guided biopolymer nanoparticle design for biomedical applications. Nanostructures with different degrees of complexity are analysed, and a proof-of-concept machine learning approach is proposed to evaluate Hydrodenticity in biopolymer matrices. STATEMENT OF SIGNIFICANCE: Size, shape and surface charge determine nano-bio interactions of nanoparticles and their ability to target diseases. The ideal nanoparticle design avoids off-target interactions and favours on-target interactions. So, tools enabling the identification of the optimal nanoparticle physicochemical properties for delivery to a specific target are required. In this work, we evaluate the use of Artificial Neural Network (ANN) to analyse the role of microfluidic parameters in predicting the optimal size of the different hydrogel nanoparticles and their ability to trigger Hydrodenticity.
Collapse
Affiliation(s)
- Alessio Smeraldo
- Department of Chemical, Materials and Production Engineering, University of Naples "Federico II", Piazzale Tecchio 80, 80125 Naples, Italy; Interdisciplinary Research Center on Biomaterials, CRIB, Piazzale Tecchio 80, 80125 Naples, Italy; Center for Advanced Biomaterials for Health Care, CABHC, Istituto Italiano di Tecnologia, IIT@CRIB, Largo Barsanti e Matteucci 53, 80125 Naples, Italy
| | - Alfonso Maria Ponsiglione
- Department of Chemical, Materials and Production Engineering, University of Naples "Federico II", Piazzale Tecchio 80, 80125 Naples, Italy
| | - Paolo Antonio Netti
- Department of Chemical, Materials and Production Engineering, University of Naples "Federico II", Piazzale Tecchio 80, 80125 Naples, Italy; Interdisciplinary Research Center on Biomaterials, CRIB, Piazzale Tecchio 80, 80125 Naples, Italy; Center for Advanced Biomaterials for Health Care, CABHC, Istituto Italiano di Tecnologia, IIT@CRIB, Largo Barsanti e Matteucci 53, 80125 Naples, Italy
| | - Enza Torino
- Department of Chemical, Materials and Production Engineering, University of Naples "Federico II", Piazzale Tecchio 80, 80125 Naples, Italy; Interdisciplinary Research Center on Biomaterials, CRIB, Piazzale Tecchio 80, 80125 Naples, Italy; Center for Advanced Biomaterials for Health Care, CABHC, Istituto Italiano di Tecnologia, IIT@CRIB, Largo Barsanti e Matteucci 53, 80125 Naples, Italy.
| |
Collapse
|
2
|
Jain V, Patel VB, Singh B, Varade D. Microfluidic Device Based Molecular Self-Assembly Structures. J Mol Liq 2022. [DOI: 10.1016/j.molliq.2022.119760] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
3
|
Ghorbanizamani F, Moulahoum H, Zihnioglu F, Timur S. Nanohybrid carriers: the yin–yang equilibrium between natural and synthetic in biomedicine. Biomater Sci 2020; 8:3237-3247. [DOI: 10.1039/d0bm00401d] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Nanocarriers are key players in biomedicine applications. The development of hybrid nanoparticles stems from the need to enhance their quality by lowering disadvantages and fusing the positive qualities of both natural and synthetic materials.
Collapse
Affiliation(s)
| | - Hichem Moulahoum
- Biochemistry Department
- Faculty of Science
- Ege University
- Bornova
- Turkey
| | - Figen Zihnioglu
- Biochemistry Department
- Faculty of Science
- Ege University
- Bornova
- Turkey
| | - Suna Timur
- Biochemistry Department
- Faculty of Science
- Ege University
- Bornova
- Turkey
| |
Collapse
|
4
|
Rezvantalab S, Keshavarz Moraveji M. Microfluidic assisted synthesis of PLGA drug delivery systems. RSC Adv 2019; 9:2055-2072. [PMID: 35516107 PMCID: PMC9059828 DOI: 10.1039/c8ra08972h] [Citation(s) in RCA: 63] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2018] [Accepted: 12/16/2018] [Indexed: 12/28/2022] Open
Abstract
Poly(lactic-co-glycolic acid) (PLGA) is a biocompatible and biodegradable polymer that recently attracted attention for use as part of drug delivery systems (DDS). In this context, there is an emerging need for a rapid, reliable and reproducible method of synthesis. Here, microfluidic systems provide great opportunities for synthesizing carriers in a tightly controlled manner and with low consumption of materials, energy and time. These miniature devices have been the focus of recent research since they can address the challenges inherent to the bulk system, e.g. low drug loading efficiency and encapsulation, broad size distribution and burst initial release. In this article, we provide an overview of current microfluidic systems used in drug delivery production, with a special focus on PLGA-based DDS. In this context, we highlight the advantages associated with the use of microchip systems in the fabrication of nanoparticles (NPs) and microparticles (MPs), e.g. in achieving complex morphologies. Furthermore, we discuss the challenges for selecting proper microfluidics for targeted DDS production in a translational setting and introduce strategies that are used to overcome microfluidics shortcomings, like low throughput for production. Poly(lactic-co-glycolic acid) (PLGA) is a biocompatible and biodegradable polymer that recently attracted attention for use as part of drug delivery systems (DDS).![]()
Collapse
Affiliation(s)
- Sima Rezvantalab
- Department of Chemical Engineering
- Amirkabir University of Technology (Tehran Polytechnic)
- Tehran
- Iran
| | | |
Collapse
|
5
|
Abstract
Catalysis is at the base of a series of biological and technological application processes. In recent years, the tendency has developed to carry out catalyzed reactions within confined structures, thus forming systems called micro or nanoreactors. Compartmentalized structures are cavities delimited by a wall where specific functions are introduced with a defined concentration and in the desired sites. These containers are generally referred to as nano or microcapsules, assuming the function of reactors in the presence of chemical reactions. Among the various types of existing structures, one of the most interesting is represented by systems made with polymers. This review aims to highlight some of the current advances in the use of functionalized structures that are useful for catalysis reactions, paying particular attention to polymer capsules and enzymes. The built-up methods used for the production of polymer capsules, as well as the aspects that influence membrane permeability and reactivity to environmental conditions, are discussed. Recent advances on biocatalysis confined in polymeric capsules are illustrated, and the strengths and weaknesses of the principal nanoreactors are considered.
Collapse
|
6
|
Damiati S, Kompella UB, Damiati SA, Kodzius R. Microfluidic Devices for Drug Delivery Systems and Drug Screening. Genes (Basel) 2018; 9:E103. [PMID: 29462948 PMCID: PMC5852599 DOI: 10.3390/genes9020103] [Citation(s) in RCA: 188] [Impact Index Per Article: 31.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2017] [Revised: 02/10/2018] [Accepted: 02/12/2018] [Indexed: 12/20/2022] Open
Abstract
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow rates of multiphase fluids, microfluidic technology enables the generation of highly stable, uniform, monodispersed particles with higher encapsulation efficiency. Since the existing preclinical models are inefficient drug screens for predicting clinical outcomes, microfluidic platforms might offer a more rapid and cost-effective alternative. Compared to 2D cell culture systems and in vivo animal models, microfluidic 3D platforms mimic the in vivo cell systems in a simple, inexpensive manner, which allows high throughput and multiplexed drug screening at the cell, organ, and whole-body levels. In this review, the generation of appropriate drug or gene carriers including different particle types using different configurations of microfluidic devices is highlighted. Additionally, this paper discusses the emergence of fabricated microfluidic cell-free protein synthesis systems for potential use at point of care as well as cell-, organ-, and human-on-a-chip models as smart, sensitive, and reproducible platforms, allowing the investigation of the effects of drugs under conditions imitating the biological system.
Collapse
Affiliation(s)
- Samar Damiati
- Department of Biochemistry, Faculty of Science, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia.
| | - Uday B Kompella
- Department of Pharmaceutical Sciences, Ophthalmology, and Bioengineering, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
| | - Safa A Damiati
- Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University (KAU), Jeddah 21589, Saudi Arabia.
| | - Rimantas Kodzius
- Mathematics and Natural Sciences Department, The American University of Iraq, Sulaimani, Sulaymaniyah 46001, Iraq.
- Materials Genome Institute, Shanghai University, Shanghai 200444, China.
- Faculty of Medicine, Ludwig Maximilian University of Munich (LMU), 80539 Munich, Germany.
- Faculty of Medicine, Technical University of Munich (TUM), 81675 Munich, Germany.
| |
Collapse
|
7
|
Marra F, De Vivo A, Sarghini F. Virtualization of fluid-dynamics in micro-air assisted extruders for food microfluidic based encapsulation. J FOOD ENG 2017. [DOI: 10.1016/j.jfoodeng.2017.04.030] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
8
|
High Yielding Microbubble Production Method. BIOMED RESEARCH INTERNATIONAL 2016; 2016:3572827. [PMID: 27034935 PMCID: PMC4789381 DOI: 10.1155/2016/3572827] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/03/2015] [Revised: 01/19/2016] [Accepted: 01/21/2016] [Indexed: 11/17/2022]
Abstract
Microfluidic approaches to microbubble production are generally disadvantaged by low yield and high susceptibility to (micro)channel blockages. This paper presents an alternative method of producing microbubbles of 2.6 μm mean diameter at concentrations in excess of 30 × 10(6) mL(-1). In this method, the nitrogen gas flowing inside the liquid jet is disintegrated into spray of microbubble when air surrounding this coflowing nitrogen gas-liquid jet passes through a 100 μm orifice at high velocity. Resulting microbubble foam has the polydispersity index of 16%. Moreover, a ratio of mean microbubble diameter to channel width ratio was found to be less than 0.025, which substantially alleviates the occurrence of blockages during production.
Collapse
|
9
|
Fabien V, Minh-Quan L, Michelle S, Guillaume B, Van-Thanh T, Marie-Claire VJ. Development of prilling process for biodegradable microspheres through experimental designs. Int J Pharm 2016; 498:96-109. [PMID: 26656302 DOI: 10.1016/j.ijpharm.2015.11.051] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2015] [Revised: 11/27/2015] [Accepted: 11/28/2015] [Indexed: 01/29/2023]
Abstract
The prilling process proposes a microparticle formulation easily transferable to the pharmaceutical production, leading to monodispersed and highly controllable microspheres. PLGA microspheres were used for carrying an encapsulated protein and adhered stem cells on its surface, proposing a tool for regeneration therapy against injured tissue. This work focused on the development of the production of PLGA microspheres by the prilling process without toxic solvent. The required production quality needed a complete optimization of the process. Seventeen parameters were studied through experimental designs and led to an acceptable production. The key parameters and mechanisms of formation were highlighted.
Collapse
Affiliation(s)
- Violet Fabien
- LUNAM Université, Micro et Nanomédecines Biomimétiques (MINT), F-49933 Angers, France; INSERM U1066, F-49933 Angers, France
| | - Le Minh-Quan
- LUNAM Université, Micro et Nanomédecines Biomimétiques (MINT), F-49933 Angers, France; INSERM U1066, F-49933 Angers, France
| | - Sergent Michelle
- Aix Marseille Université, LISA, EA 4672, 13013 Marseille, France
| | - Bastiat Guillaume
- LUNAM Université, Micro et Nanomédecines Biomimétiques (MINT), F-49933 Angers, France; INSERM U1066, F-49933 Angers, France
| | - Tran Van-Thanh
- LUNAM Université, Micro et Nanomédecines Biomimétiques (MINT), F-49933 Angers, France; INSERM U1066, F-49933 Angers, France
| | - Venier-Julienne Marie-Claire
- LUNAM Université, Micro et Nanomédecines Biomimétiques (MINT), F-49933 Angers, France; INSERM U1066, F-49933 Angers, France.
| |
Collapse
|
10
|
Cuomo F, Lopez F, Ceglie A. Templated globules--applications and perspectives. Adv Colloid Interface Sci 2014; 205:124-33. [PMID: 24011695 DOI: 10.1016/j.cis.2013.08.003] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2013] [Accepted: 08/11/2013] [Indexed: 12/21/2022]
Abstract
Polyelectrolyte capsules represent a class of particles composed of an internal core and an external polymer matrix shell. In recent years, it has become clear that the manufacture of polyelectrolyte capsule is likely to have a significant role in several areas including medicine and biology. Many distinct methodologies for the fabrications of templated globules have been reported. Despite the huge availability of knowledge used to obtain such globules, the choice of the appropriate technology for the desired applications demands a deeper appreciation of this issue. Furthermore, the extent to which the applications of polyelectrolyte capsule may be actively involved in the practical biomedical field is still a fascinating challenge. Here, we review the recipes for the globule assembly with their own benefits and limitations and how different templates could affect the final globule features, with a particular focus on the Layer by Layer (LbL) procedure. The latest applications in biological, therapeutical and diagnostic areas are also discussed and some outlooks for the strategic development of polymer globule are highlighted.
Collapse
|
11
|
Mitropoulos AN, Perotto G, Kim S, Marelli B, Kaplan DL, Omenetto FG. Synthesis of silk fibroin micro- and submicron spheres using a co-flow capillary device. ADVANCED MATERIALS (DEERFIELD BEACH, FLA.) 2014; 26:1105-1110. [PMID: 24339048 DOI: 10.1002/adma.201304244] [Citation(s) in RCA: 47] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/22/2013] [Indexed: 05/28/2023]
Abstract
A custom-made co-flow capillary device is used to synthesize monodisperse silk fibroin micro- and submicron-spheres with diameters tunable over a wide range of sizes. A model drug release is examined and control of degradation kinetics is obtained by changing sphere diameter.
Collapse
Affiliation(s)
- Alexander N Mitropoulos
- Department of Biomedical Engineering, Tufts University, 4 Colby St., Medford, MA, 02155, USA
| | | | | | | | | | | |
Collapse
|
12
|
Vladisavljević GT, Khalid N, Neves MA, Kuroiwa T, Nakajima M, Uemura K, Ichikawa S, Kobayashi I. Industrial lab-on-a-chip: design, applications and scale-up for drug discovery and delivery. Adv Drug Deliv Rev 2013; 65:1626-63. [PMID: 23899864 DOI: 10.1016/j.addr.2013.07.017] [Citation(s) in RCA: 156] [Impact Index Per Article: 14.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2013] [Revised: 07/16/2013] [Accepted: 07/18/2013] [Indexed: 01/09/2023]
Abstract
Microfluidics is an emerging and promising interdisciplinary technology which offers powerful platforms for precise production of novel functional materials (e.g., emulsion droplets, microcapsules, and nanoparticles as drug delivery vehicles- and drug molecules) as well as high-throughput analyses (e.g., bioassays, detection, and diagnostics). In particular, multiphase microfluidics is a rapidly growing technology and has beneficial applications in various fields including biomedicals, chemicals, and foods. In this review, we first describe the fundamentals and latest developments in multiphase microfluidics for producing biocompatible materials that are precisely controlled in size, shape, internal morphology and composition. We next describe some microfluidic applications that synthesize drug molecules, handle biological substances and biological units, and imitate biological organs. We also highlight and discuss design, applications and scale up of droplet- and flow-based microfluidic devices used for drug discovery and delivery.
Collapse
|
13
|
Gañán-Calvo A, Montanero J, Martín-Banderas L, Flores-Mosquera M. Building functional materials for health care and pharmacy from microfluidic principles and Flow Focusing. Adv Drug Deliv Rev 2013; 65:1447-69. [PMID: 23954401 DOI: 10.1016/j.addr.2013.08.003] [Citation(s) in RCA: 46] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2013] [Revised: 08/02/2013] [Accepted: 08/02/2013] [Indexed: 12/11/2022]
Abstract
In this review, we aim at establishing a relationship between the fundamentals of the microfluidics technologies used in the Pharmacy field, and the achievements accomplished by those technologies. We describe the main methods for manufacturing micrometer drops, bubbles, and capsules, as well as the corresponding underlying physical mechanisms. In this regard, the review is intended to show non-specialist readers the dynamical processes which determine the success of microfluidics techniques. Flow focusing (FF) is a droplet-based method widely used to produce different types of fluid entities on a continuous basis by applying an extensional co-flow. We take this technique as an example to illustrate how microfluidics technologies for drug delivery are progressing from a deep understanding of the physics of fluids involved. Specifically, we describe the limitations of FF, and review novel methods which enhance its stability and robustness. In the last part of this paper, we review some of the accomplishments of microfluidics when it comes to drug manufacturing and delivery. Special attention is paid to the production of the microencapsulated form because this fluidic structure gathers the main functionalities sought for in Pharmacy. We also show how FF has been adapted to satisfy an ample variety of pharmaceutical requirements to date.
Collapse
|
14
|
Yu Q, Tao Y, Huang Y, Lin Z, Zhuang Y, Ge L, Shen Y, Hong M, Xie A. Preparation of Porous Polysulfone Microspheres and Their Application in Removal of Oil from Water. Ind Eng Chem Res 2012. [DOI: 10.1021/ie203028h] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Qingbo Yu
- Department of Materials Science
and Engineering, Anhui University of Science and Technology, Huainan 232001, PR China
| | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Marques MP, Fernandes P. Microfluidic devices: useful tools for bioprocess intensification. Molecules 2011; 16:8368-401. [PMID: 21963626 PMCID: PMC6264232 DOI: 10.3390/molecules16108368] [Citation(s) in RCA: 76] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2011] [Revised: 09/21/2011] [Accepted: 09/28/2011] [Indexed: 11/16/2022] Open
Abstract
The dawn of the new millennium saw a trend towards the dedicated use of microfluidic devices for process intensification in biotechnology. As the last decade went by, it became evident that this pattern was not a short-lived fad, since the deliverables related to this field of research have been consistently piling-up. The application of process intensification in biotechnology is therefore seemingly catching up with the trend already observed in the chemical engineering area, where the use of microfluidic devices has already been upgraded to production scale. The goal of the present work is therefore to provide an updated overview of the developments centered on the use of microfluidic devices for process intensification in biotechnology. Within such scope, particular focus will be given to different designs, configurations and modes of operation of microreactors, but reference to similar features regarding microfluidic devices in downstream processing will not be overlooked. Engineering considerations and fluid dynamics issues, namely related to the characterization of flow in microchannels, promotion of micromixing and predictive tools, will also be addressed, as well as reflection on the analytics required to take full advantage of the possibilities provided by microfluidic devices in process intensification. Strategies developed to ease the implementation of experimental set-ups anchored in the use of microfluidic devices will be briefly tackled. Finally, realistic considerations on the current advantages and limitation on the use of microfluidic devices for process intensification, as well as prospective near future developments in the field, will be presented.
Collapse
Affiliation(s)
- Marco P.C. Marques
- Department of Bioengineering, Instituto Superior Técnico (IST), Universidade Técnica de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal
- IBB-Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, IST, Lisboa, Portugal
| | - Pedro Fernandes
- Department of Bioengineering, Instituto Superior Técnico (IST), Universidade Técnica de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal
- IBB-Institute for Biotechnology and Bioengineering, Centre for Biological and Chemical Engineering, IST, Lisboa, Portugal
| |
Collapse
|